
This video examines findings from the International Breast Cancer Intervention Study (IBIS-1), which found that patients with menopause symptoms were less likely to continue long-term tamoxifen therapy.

Your AI-Trained Oncology Knowledge Connection!


Published: January 14th 2017 | Updated: